Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:45 UTC |
---|
HMDB ID | HMDB0014834 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Ergotamine |
---|
Description | Ergotamine is only found in individuals that have used or taken this drug. It is a vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders. [PubChem]Ergotamine acts on migraine by one of two proposed mechanisms: 1) activation of 5-HT1D receptors located on intracranial blood vessels, including those on arterio-venous anastomoses, leads to vasoconstriction, which correlates with the relief of migraine headache, and 2) activation of 5-HT1D receptors on sensory nerve endings of the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release. |
---|
Structure | [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1 |
---|
Synonyms | Value | Source |
---|
(5'alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione | ChEBI | 12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione | ChEBI | Ergotamin | ChEBI | Ergotamina | ChEBI | Ergotaminum | ChEBI | Gynergen | ChEBI | (5'a)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione | Generator | (5'Α)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione | Generator | 12'-Hydroxy-2'-methyl-5'a-(phenylmethyl)ergotaman-3',6',18-trione | Generator | 12'-Hydroxy-2'-methyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione | Generator | Cornutamine | HMDB | Ergotaminine | HMDB | Lingraine | HMDB | Tartrate, ergotamine | HMDB | ErgoKranit | HMDB | Ergo-kranit | HMDB | Ergotamine tartrate (2:1) | HMDB | mono, Ergodryl | HMDB | Pfizer brand OF ergotamine tartrate | HMDB | Ergo sanol | HMDB | Ergo kranit | HMDB | Ergodryl mono | HMDB | Ergomar | HMDB | Ergostat | HMDB | Ergotamine tartrate | HMDB | Krewel brand OF ergotamine tartrate | HMDB | Lotus brand OF ergotamine tartrate | HMDB | Sanofi winthrop brand OF ergotamine tartrate | HMDB |
|
---|
Chemical Formula | C33H35N5O5 |
---|
Average Molecular Weight | 581.6615 |
---|
Monoisotopic Molecular Weight | 581.263819255 |
---|
IUPAC Name | (4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide |
---|
Traditional Name | ergomar |
---|
CAS Registry Number | 113-15-5 |
---|
SMILES | [H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O |
---|
InChI Identifier | InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1 |
---|
InChI Key | XCGSFFUVFURLIX-VFGNJEKYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as ergotamines, dihydroergotamines, and derivatives. These are organic compounds containing an ergotamine moiety, which is structurally characterized by a benzyl substituent attached to the piperazine ring of the ergopeptine backbone. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Ergoline and derivatives |
---|
Sub Class | Lysergic acids and derivatives |
---|
Direct Parent | Ergotamines, dihydroergotamines, and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Ergotamine
- Hybrid peptide
- Alpha-dipeptide
- Lysergic acid amide
- Indoloquinoline
- Benzoquinoline
- Quinoline-3-carboxamide
- N-acyl-alpha amino acid or derivatives
- Pyrroloquinoline
- Quinoline
- Alpha-amino acid or derivatives
- 3-alkylindole
- Indole
- Indole or derivatives
- Isoindole or derivatives
- Aralkylamine
- N-alkylpiperazine
- Monocyclic benzene moiety
- 1,4-diazinane
- Benzenoid
- Oxazolidinone
- Piperazine
- Pyrrole
- Pyrrolidine
- Heteroaromatic compound
- Oxazolidine
- Tertiary carboxylic acid amide
- Carboxamide group
- Tertiary amine
- Amino acid or derivatives
- Lactam
- Tertiary aliphatic amine
- Secondary carboxylic acid amide
- Orthocarboxylic acid derivative
- Carboxylic acid derivative
- Organoheterocyclic compound
- Alkanolamine
- Oxacycle
- Azacycle
- Organooxygen compound
- Organic nitrogen compound
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Amine
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 213.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.22 g/L | Not Available | LogP | 2 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ergotamine,1TMS,isomer #1 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 4759.5 | Semi standard non polar | 33892256 | Ergotamine,1TMS,isomer #2 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 4622.8 | Semi standard non polar | 33892256 | Ergotamine,1TMS,isomer #3 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 4694.6 | Semi standard non polar | 33892256 | Ergotamine,2TMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 4639.4 | Semi standard non polar | 33892256 | Ergotamine,2TMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 4731.6 | Standard non polar | 33892256 | Ergotamine,2TMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 6233.0 | Standard polar | 33892256 | Ergotamine,2TMS,isomer #2 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 4672.6 | Semi standard non polar | 33892256 | Ergotamine,2TMS,isomer #2 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 4660.1 | Standard non polar | 33892256 | Ergotamine,2TMS,isomer #2 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 6234.2 | Standard polar | 33892256 | Ergotamine,2TMS,isomer #3 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 4573.6 | Semi standard non polar | 33892256 | Ergotamine,2TMS,isomer #3 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 4689.0 | Standard non polar | 33892256 | Ergotamine,2TMS,isomer #3 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 6231.5 | Standard polar | 33892256 | Ergotamine,3TMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 4600.6 | Semi standard non polar | 33892256 | Ergotamine,3TMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 4680.6 | Standard non polar | 33892256 | Ergotamine,3TMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C)C[C@H]21 | 5987.9 | Standard polar | 33892256 | Ergotamine,1TBDMS,isomer #1 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O[Si](C)(C)C(C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 4942.8 | Semi standard non polar | 33892256 | Ergotamine,1TBDMS,isomer #2 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C(C)(C)C)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 4830.5 | Semi standard non polar | 33892256 | Ergotamine,1TBDMS,isomer #3 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C(C)(C)C)C[C@H]21 | 4878.3 | Semi standard non polar | 33892256 | Ergotamine,2TBDMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C(C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C(C)(C)C)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 5016.2 | Semi standard non polar | 33892256 | Ergotamine,2TBDMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C(C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C(C)(C)C)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 5151.3 | Standard non polar | 33892256 | Ergotamine,2TBDMS,isomer #1 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O[Si](C)(C)C(C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C(C)(C)C)C=C2C3=CC=CC4=C3C(=C[NH]4)C[C@H]21 | 6256.1 | Standard polar | 33892256 | Ergotamine,2TBDMS,isomer #2 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O[Si](C)(C)C(C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C(C)(C)C)C[C@H]21 | 5038.1 | Semi standard non polar | 33892256 | Ergotamine,2TBDMS,isomer #2 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O[Si](C)(C)C(C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C(C)(C)C)C[C@H]21 | 5060.0 | Standard non polar | 33892256 | Ergotamine,2TBDMS,isomer #2 | CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O[Si](C)(C)C(C)(C)C)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C(C)(C)C)C[C@H]21 | 6288.3 | Standard polar | 33892256 | Ergotamine,2TBDMS,isomer #3 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C(C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C(C)(C)C)C[C@H]21 | 4952.8 | Semi standard non polar | 33892256 | Ergotamine,2TBDMS,isomer #3 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C(C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C(C)(C)C)C[C@H]21 | 5076.9 | Standard non polar | 33892256 | Ergotamine,2TBDMS,isomer #3 | CN1C[C@H](C(=O)N([C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)[Si](C)(C)C(C)(C)C)C=C2C3=CC=CC4=C3C(=CN4[Si](C)(C)C(C)(C)C)C[C@H]21 | 6283.9 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Ergotamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0gi0-6692120000-7fabddfa08a8dd219bc3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ergotamine GC-MS (1 TMS) - 70eV, Positive | splash10-0g4j-9281023000-06e454bbac7ea8189ead | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ergotamine GC-MS ("Ergotamine,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ergotamine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ergotamine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ergotamine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ergotamine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ergotamine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-15 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 10V, Positive-QTOF | splash10-001i-0022090000-66faf61c3242915f91f8 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 20V, Positive-QTOF | splash10-0uyi-0091010000-98b25c5586801771014a | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 40V, Positive-QTOF | splash10-00di-4290000000-42f48d5180d5f2f5c20e | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 10V, Negative-QTOF | splash10-0019-0049160000-6be92986c4d5c2bd6dad | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 20V, Negative-QTOF | splash10-0aor-2196220000-c51c3bf00ec927a5631b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 40V, Negative-QTOF | splash10-0g5a-9810000000-7522033f4e775f417ffa | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 10V, Positive-QTOF | splash10-001i-0000090000-34b8023f9528c85e96bc | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 20V, Positive-QTOF | splash10-001i-0020190000-ec8f5848bc681f03dbe9 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 40V, Positive-QTOF | splash10-00di-0090020000-c4d316e57df458ef5f72 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 10V, Negative-QTOF | splash10-001i-0000090000-7dfa0cf0a740c633816a | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 20V, Negative-QTOF | splash10-001i-2100390000-8129f2d9526dbde472d8 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ergotamine 40V, Negative-QTOF | splash10-0fvi-9252430000-c9d112acb2b7bf8de124 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|